An Engineered ACE2 Decoy Neutralizes the SARS-CoV-2 Omicron Variant and Confers Protection against Infection In Vivo

Scientists analyzed the degree to which Omicron pseudovirus evaded neutralization by serum or therapeutic antibodies.